Tesla is forging ahead with its ambitious Terafab chip initiative, a move that could result in capital expenditures significantly surpassing earlier estimates. Analysts at Barclays have cautioned that the project’s costs could escalate rapidly, potentially reaching staggering levels. They argue that Tesla’s initial projection of $20 billion is overly cautious. Elon Musk has unveiled plans for Terafab, estimating its total cost to range between $25 billion and $40 billion. The goal is to construct a cutting-edge 2-nanometer semiconductor fabrication facility dedicated to producing AI chips. These chips are earmarked for Tesla’s autonomous driving systems, the upcoming Cybercab self-driving taxi, and the Optimus robot.

Despite Tesla’s limited experience in semiconductor manufacturing, Musk remains optimistic, envisioning a factory whose scale will rival—or even surpass—industry giants like TSMC. Looking ahead, Tesla anticipates its capital expenditures for 2026 will exceed $20 billion. The company’s latest 10-K annual report underscores the necessity of securing additional financing to support these ambitious plans. Given the recent downturn in automotive business revenue, Tesla’s free cash flow may dip into negative territory. As a result, the company faces the delicate task of balancing its aggressive expansion goals with the need to raise substantial funds.